• InstaBlue Protein Stain Solution: Assay Design

  2026-09-12

  InstaBlue Protein Stain Solution can turn rapid gel staining into a more deliberate analytical decision point. This article connects Coomassie-based visualization with PRMT6-mediated antiviral research, clarifying what a stained gel can prove, what it cannot, and how to preserve samples for downstream analysis.

• Fast-Dissociating Antibodies from Hybridoma Cultures

  2026-09-12

  Miyoshi et al. developed a semi-automated single-molecule TIRF assay that identifies specific, fast-dissociating monoclonal antibodies directly from hybridoma cultures. The resulting Fab probes enabled multiplex super-resolution imaging and revealed rapid espin turnover within long-lived actin cores of inner-ear hair-cell stereocilia.

• DPF2 Splicing Rewires Stem and Neuronal Programs

  2026-09-11

  The reference study shows that PTBP1-directed alternative splicing changes the DPF2 subunit of BAF chromatin-remodeling complexes during neuronal differentiation. Its findings connect an RNA-processing switch to isoform-specific chromatin occupancy, transcription-factor associations, and developmental gene regulation.

• CARMIL Membrane Binding Controls Actin Assembly

  2026-09-11

  Mooren and colleagues show that the CARMIL membrane-binding domain is an active regulator of capping protein, not merely a membrane tether. Their biochemical results explain how CARMIL can recruit capping protein to lipid surfaces, promote localized actin assembly, and then release from the membrane after capping protein engagement.

• Lithium, Exosomal Wnt10a, and Bone Regeneration

  2026-09-10

  The 2024 ACS Applied Materials & Interfaces study shows that lithium enhances BMSC osteogenesis by promoting Rab11a/Rab11FIP1-dependent trafficking and secretion of exosomal Wnt10a, thereby activating β-catenin signaling. Lithium-conditioned exosomes and GelMA formulations improved osteogenic differentiation and bone repair, providing a mechanistic basis for engineering exosome-based regenerative therapies.

• Protease Inhibitor Cocktail for MS Proteomics

  2026-09-10

  Discover how a Protease Inhibitor Cocktail can preserve fragile signaling proteins during extraction and MS proteomics. This article uses CYR61–migrasome biology to explain assay decisions beyond routine protein degradation prevention.

• TBXA2R–ERM Signaling in TNBC Metastasis

  2026-09-09

  Leguay et al. identify TBXA2R as an upstream GPCR that activates ezrin, radixin, and moesin through Gαq/11, Gα12/13, Rho GTPases, SLK, and LOK. The resulting TBXA2R–ERM axis connects receptor signaling to triple-negative breast cancer motility, invasion, and metastatic colonization, providing a mechanistic framework for studying GPCR-controlled cytoskeletal remodeling.

• Mdivi-1: Selective DRP1 Inhibitor Guide

  2026-09-09

  Mdivi-1 is a cell-permeable selective DRP1 inhibitor used to investigate mitochondrial fission, apoptosis, and neuroprotection. Its effects should be interpreted with orthogonal readouts because published evidence also identifies mitochondrial complex I inhibition as a potential confounder.

• MCL-1 Dependence in Breast Cancer: Study Insights

  2026-09-08

  The reference study shows that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic activity, rather than because of an independent non-apoptotic function. By combining genetic deletion, pharmacological inhibition, BAX/BAK epistasis, and stem-cell analyses, the work clarifies how MCL-1 targeting can be interpreted in breast cancer research.

• Epacadostat: IDO1 Control in Whole-Blood Assays

  2026-09-07

  Epacadostat (INCB024360) provides a precise way to interrogate IDO1-dependent tryptophan metabolism in immuno-oncology research. This guide shows how to integrate the compound with standardized whole-blood stimulation while separating enzyme inhibition from broader immunometabolic effects.

• BCA Protein Quantification Kit K4102

  2026-09-07

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 provides sensitive total-protein measurement for dilute samples, including many detergent-containing biochemical preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and is not for diagnostic, clinical, or medical use.

• GANT61 and the GLI2-PRDX1 Ferroptosis Axis

  2026-09-05

  A translational framework for using GANT61 to test how GLI2-driven transcription, PRDX1, ferroptosis, and cisplatin response intersect in bladder cancer research.

• Gepotidacin: From Assay Signal to Clinical Meaning

  2026-09-04

  Gepotidacin, also known as GSK2140944, links an unconventional topoisomerase mechanism to clinically meaningful urinary tract infection outcomes. This article provides an assay-to-clinic framework for interpreting potency, DNA damage, resistance, and translational evidence in antibacterial research.

• High-Throughput BBB Permeability Model Explained

  2026-09-04

  The reference study develops a paired LLC-PK1-MOCK/MDR1 Transwell model that combines barrier integrity testing, bidirectional transport, and lysosomal-trapping correction for faster blood-brain barrier permeability assessment. Its correlation with unbound brain distribution supports mechanism-aware prioritization of CNS candidates while clarifying the limitations of simplified in vitro systems.

• EDC.HCl: Practical Coupling Workflow Guide

  2026-09-04

  EDC.HCl is a water-soluble carbodiimide coupling reagent for activating carboxyl groups and supporting amide bond formation with primary amines in peptide, bioconjugation, and related in vitro workflows. This dossier-based guide covers preparation, QC, and troubleshooting; the reagent should not be used for in vivo or clinical applications without separate validation.

8527 records 1/569 page Next 12345 下5页 Last page